Harmony Biosciences (HRMY) Competitors $30.97 -1.56 (-4.80%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$28.09 -2.88 (-9.31%) As of 06:37 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HRMY vs. ROIV, SRPT, RVMD, BBIO, LNTH, TGTX, LEGN, AXSM, TLX, and BPMCShould you be buying Harmony Biosciences stock or one of its competitors? The main competitors of Harmony Biosciences include Roivant Sciences (ROIV), Sarepta Therapeutics (SRPT), Revolution Medicines (RVMD), BridgeBio Pharma (BBIO), Lantheus (LNTH), TG Therapeutics (TGTX), Legend Biotech (LEGN), Axsome Therapeutics (AXSM), Telix Pharmaceuticals Limited American Depositary Shares (TLX), and Blueprint Medicines (BPMC). These companies are all part of the "pharmaceutical products" industry. Harmony Biosciences vs. Roivant Sciences Sarepta Therapeutics Revolution Medicines BridgeBio Pharma Lantheus TG Therapeutics Legend Biotech Axsome Therapeutics Telix Pharmaceuticals Limited American Depositary Shares Blueprint Medicines Harmony Biosciences (NASDAQ:HRMY) and Roivant Sciences (NASDAQ:ROIV) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, community ranking, valuation, media sentiment, earnings and analyst recommendations. Do analysts rate HRMY or ROIV? Harmony Biosciences currently has a consensus target price of $53.33, suggesting a potential upside of 72.21%. Roivant Sciences has a consensus target price of $17.50, suggesting a potential upside of 74.83%. Given Roivant Sciences' higher possible upside, analysts clearly believe Roivant Sciences is more favorable than Harmony Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Harmony Biosciences 0 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 3.00Roivant Sciences 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more volatility & risk, HRMY or ROIV? Harmony Biosciences has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500. Comparatively, Roivant Sciences has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500. Is HRMY or ROIV more profitable? Harmony Biosciences has a net margin of 17.98% compared to Roivant Sciences' net margin of -119.54%. Harmony Biosciences' return on equity of 23.16% beat Roivant Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Harmony Biosciences17.98% 23.16% 14.24% Roivant Sciences -119.54%-14.05%-12.81% Does the MarketBeat Community believe in HRMY or ROIV? Harmony Biosciences received 10 more outperform votes than Roivant Sciences when rated by MarketBeat users. However, 78.26% of users gave Roivant Sciences an outperform vote while only 70.33% of users gave Harmony Biosciences an outperform vote. CompanyUnderperformOutperformHarmony BiosciencesOutperform Votes6470.33% Underperform Votes2729.67% Roivant SciencesOutperform Votes5478.26% Underperform Votes1521.74% Which has better earnings and valuation, HRMY or ROIV? Roivant Sciences has lower revenue, but higher earnings than Harmony Biosciences. Roivant Sciences is trading at a lower price-to-earnings ratio than Harmony Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHarmony Biosciences$714.73M2.48$128.85M$2.5112.34Roivant Sciences$122.59M58.27$4.35B-$0.15-66.73 Do insiders & institutionals believe in HRMY or ROIV? 86.2% of Harmony Biosciences shares are held by institutional investors. Comparatively, 64.8% of Roivant Sciences shares are held by institutional investors. 30.8% of Harmony Biosciences shares are held by insiders. Comparatively, 7.9% of Roivant Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media prefer HRMY or ROIV? In the previous week, Harmony Biosciences and Harmony Biosciences both had 9 articles in the media. Roivant Sciences' average media sentiment score of 1.36 beat Harmony Biosciences' score of 0.97 indicating that Roivant Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Harmony Biosciences 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Roivant Sciences 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryHarmony Biosciences beats Roivant Sciences on 10 of the 17 factors compared between the two stocks. Remove Ads Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HRMY vs. The Competition Export to ExcelMetricHarmony BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.78B$6.73B$5.54B$7.49BDividend YieldN/A2.79%5.35%4.04%P/E Ratio14.686.9923.2518.07Price / Sales2.48198.60361.2686.83Price / Cash13.3865.6738.1634.64Price / Book3.895.926.493.99Net Income$128.85M$142.37M$3.21B$247.18M7 Day Performance-7.14%-9.32%-6.42%-6.42%1 Month Performance-3.76%-10.26%-0.68%-7.44%1 Year Performance-2.30%-15.08%6.05%-4.31% Harmony Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HRMYHarmony Biosciences4.3936 of 5 stars$30.97-4.8%$53.33+72.2%-2.3%$1.87B$714.73M14.68200ROIVRoivant Sciences2.3564 of 5 stars$10.83+0.4%$18.08+67.0%-13.0%$7.73B$122.59M-72.20860SRPTSarepta Therapeutics4.7926 of 5 stars$76.33+3.0%$167.41+119.3%-53.8%$7.41B$1.90B61.061,314Analyst UpgradeOptions VolumeRVMDRevolution Medicines4.12 of 5 stars$39.34+3.2%$66.31+68.6%+4.7%$7.31B$742,000.00-10.96250Analyst ForecastPositive NewsGap DownBBIOBridgeBio Pharma4.5869 of 5 stars$37.22+7.0%$52.90+42.1%+16.6%$7.08B$221.90M-13.06400Insider TradeGap DownHigh Trading VolumeLNTHLantheus4.3264 of 5 stars$99.44+1.8%$129.43+30.2%+64.2%$6.81B$1.53B16.55700Positive NewsGap DownTGTXTG Therapeutics2.8877 of 5 stars$42.61-0.9%$40.67-4.6%+171.9%$6.69B$329.00M-426.06290Positive NewsGap DownLEGNLegend Biotech2.5889 of 5 stars$36.33-1.7%$79.00+117.5%-41.7%$6.67B$627.24M-38.241,800Short Interest ↓News CoveragePositive NewsAXSMAxsome Therapeutics4.6673 of 5 stars$129.17+1.9%$167.36+29.6%+46.8%$6.30B$385.69M-21.56380Analyst ForecastShort Interest ↓Gap DownTLXTelix Pharmaceuticals Limited American Depositary SharesN/A$18.24+2.5%$22.00+20.6%N/A$6.14B$783.21M0.00N/AGap UpBPMCBlueprint Medicines2.7306 of 5 stars$95.27+7.4%$124.95+31.2%-5.6%$6.09B$508.82M-88.21640News CoveragePositive NewsGap Down Remove Ads Related Companies and Tools Related Companies Roivant Sciences Alternatives Sarepta Therapeutics Alternatives Revolution Medicines Alternatives BridgeBio Pharma Alternatives Lantheus Alternatives TG Therapeutics Alternatives Legend Biotech Alternatives Axsome Therapeutics Alternatives Telix Pharmaceuticals Limited American Depositary Shares Alternatives Blueprint Medicines Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HRMY) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harmony Biosciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harmony Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
